| ID LINK | NAME | STRUCTURE CAS | CLOGP | CLOGS | MW | THERAPEUTIC AREA |
|---|---|---|---|---|---|---|
| FDBD00166 | Liothyronine |
 6893-02-3 |
4.581 | -5.269 | 650.973 | Used as replacement or supplemental therapy in patients with hypothyroidism of any etiology, except transient hypothyrodism during the recovery phase of subacute thyroiditis. |
| FDBD00167 | Disopyramide |
 3737-09-5 |
3.530 | -4.577 | 339.474 | For the treatment of documented ventricular arrhythmias, such as sustained ventricular tachycardia, ventricular pre-excitation and cardiac dysrhythmias. It is a Class Ia antiarrhythmic drug. |
| FDBD00168 | Lidocaine |
 137-58-6 |
2.640 | -4.051 | 234.337 | For production of local or regional anesthesia by infiltration techniques such as percutaneous injection and intravenous regional anesthesia by peripheral nerve block techniques such as brachial plexus and intercostal and by central neural techniques such as lumbar and caudal epidural blocks. |
| FDBD00169 | Pamidronate |
 40391-99-9 |
-3.433 | 2.452 | 235.069 | For the treatment of moderate or severe hypercalcemia associated with malignancy. |
| FDBD00170 | Clemastine |
 15686-51-8 |
5.146 | -5.720 | 343.890 | For the relief of symptoms associated with allergic rhinitis such as sneezing, rhinorrhea, pruritus and acrimation. Also for the management of mild, uncomplicated allergic skin manifestations of urticaria and angioedema. Used as self-medication for temporary relief of symptoms associated with the common cold. |
| FDBD00171 | Acarbose |
 56180-94-0 |
-7.687 | 6.400 | 645.605 | For treatment and management of diabetes type II (used in combination therapy as a second or third line agent). |
| FDBD00172 | Venlafaxine |
 93413-69-5 |
3.186 | -3.563 | 277.402 | For the management of major depressive disorder (MDD), generalized anxiety disorder (GAD), social anxiety disorder (social phobia), panic disorder with or without agoraphobia, vasomotor symptoms in women with breast cancer and in postmenopausal women, and neuropathic pain. |
| FDBD00174 | Travoprost |
 157283-68-6 |
5.238 | -3.745 | 500.548 | Ophthalmic solution used for the reduction of elevated intraocular pressure in patients with open-angle glaucoma or ocular hypertension who are intolerant of other intraocular pressure lowering medications or insufficiently responsive (failed to achieve target IOP determined after multiple measurements over time) to another intraocular pressure lowering medication. |
| FDBD00175 | Amcinonide |
 51022-69-6 |
3.840 | -4.377 | 502.572 | For the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses. |
| FDBD00176 | Atomoxetine |
 83015-26-3 |
4.034 | -4.981 | 255.355 | For the treatment of Attention-Deficit/Hyperactivity Disorder (ADHD) alone or in combination with behavioral treatment, as an adjunct to psychological, educational, social, and other remedial measures. |
2911 ,
292
